Reporting owner · CIK 0002009762

Budur Kumar

Visual SEC Form 4 history across 1 companies, 13 transactions and 2 filings.

CMOCHIEF MEDICAL OFFICERHarmony Biosciences Holdings, Inc.
Open-market mix
Latest filingSep 09, 2026, 09:12 PM
Filings2Form 4 records
Buying$00 purchases
Selling$1.5M4 sales
Net value−$1.5MBuys minus sells
Companies13 securities
Most recentSep 08, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Jan 254Sep 26

Net value flow

Buys minus sells

Jan 25
$0
Sep 26
−$1.5M

Transaction texture

Ownership and ticket size

Average P/S size$363.3K
Median P/S size$210.5K
Direct13
Indirect0
Sep 08, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context3Direct Ownershipfiling-context5Large Holdings Increaseholdings3Large Holdings Reductionholdings2

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Harmony Biosciences Holdings, Inc. on Sep 08, 2026 valued at $989,350.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Harmony Biosciences Holdings, Inc. on Sep 08, 2026 valued at $989,350.

Review SEC filing

Associated companies

Visual map of known reporting history

HRMYHarmony Biosciences Holdings, Inc.13 transactions · latest Sep 09, 2026, 09:12 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
HRMYBudur Kumar
CMO
exercise10b5-110.7k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
—09/0909/08
HRMYBudur Kumar
CMO
exercise10b5-112.2k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—09/0909/08
HRMYBudur Kumar
CMO
sale10b5-122.9k-$98.9MS
Direct Ownership Large Holdings Reduction Large Sale+2
—09/0909/08
HRMYBudur Kumar
CMO
exercise10b5-110.7k$32.5MM
Direct Ownership Large Holdings Increase 10b5-1 Detected
—09/0909/08
HRMYBudur Kumar
CMO
exercise10b5-112.2k$37.4MM
Direct Ownership Large Holdings Increase 10b5-1 Detected
—09/0909/08
HRMYBudur Kumar
CMO
sale10b5-11.00k-$4.27MS
Direct Ownership Repeat Seller 10b5-1 Detected
—09/0909/08
HRMYBudur Kumar
CMO
sale10b5-14.50k-$19.0MS
Direct Ownership Large Holdings Reduction Repeat Seller+1
—09/0909/08
HRMYBudur Kumar
CMO
sale10b5-15.50k-$23.0MS
Direct Ownership Large Holdings Reduction 10b5-1 Detected
—09/0909/04
HRMYBudur Kumar
CMO
grant10.6k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/28/202501/25/2025
HRMYBudur Kumar
CMO
grant37.4k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/28/202501/25/2025

Budur Kumar Insider Activity FAQ

SEC Form 4 context

Who is Budur Kumar?

Budur Kumar is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002009762.

Which companies has Budur Kumar reported transactions for?

Harmony Biosciences Holdings, Inc.

When was Budur Kumar's latest insider buy?

No open-market insider purchase is available for this period.

When was Budur Kumar's latest insider sale?

sale at Harmony Biosciences Holdings, Inc. on Sep 08, 2026 valued at $989,350.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.